Naturally Splendid (TSXV:NSP) announced that its board of directors have approved a proposed private placement offering of a minimum of 5,555,555 units up to a maximum of 9,259,259 Units at a price of $0.27 per Unit for minimum gross proceeds of $1,500,000 and up to maximum gross proceeds of $2,500,000.
Naturally Splendid CEO, Craig Goodwin, stated:

We continue to increase sales through several channels including exports, our 100% owned retail lines as well as the POS Bio Processing Centre (POS BPC). On July 1, 2016, the Company will be moving to its new expanded location in the Greater Vancouver Region to accommodate the increased product flow and sales. This raise allows us to continue our aggressive exporting strategy and add to our South Korean success with exports to additional countries in Asia and Europe. We are currently at an advanced stage of negotiations with three countries for bulk and retail exports of our hemp based products including HempOmega™.
We will also direct funds towards commercializing and monetizing our Cannabidiol (CBD) technologies and products, as regulatory issues continue to clear resulting in fewer legal challenges in this highly regulated market, subject to TSXV regulatory approval. As with emerging opportunities, timing is of utmost importance and we are well positioned to penetrate this market as that time nears. We believe it is just a matter of time until the CBD regulations are relaxed allowing for neutraceutical grade CBD products.


Connect with Naturally Splendid (TSXV:NSP) to receive an Investor Presentation.

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /

Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less

The following issues have been halted by IIROC:

Company: Revive Therapeutics Ltd.

Keep reading... Show less